Thirona has partnered with AI solutions provider Blackford to integrate Thirona's LungQ solution into the Blackford Platform.
The LungQ software assists in the efficient diagnosis and treatment planning for chronic obstructive pulmonary disease (COPD). The technology provides precise diagnoses, personalized treatment plans, and disease progression tracking to improve patient outcomes.
Netherlands-based Thirona specializes in the field of medical image analysis using AI. The company develops software tools for analyzing thoracic CT scans, chest X-rays, and retinal images. Its flagship product, LungQ, leverages AI to provide detailed segmentation and analysis of lung structures, aiding in the diagnosis and treatment planning of lung diseases such as COPD and lung cancer.
Analyst QuickTake : The latest version of LungQ (v3.0.0) received FDA 510(k) clearance in January 2024. It is one of the only FDA-cleared solutions capable of segmenting the pulmonary segments and subsegments found in the lung's internal anatomy using AI.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.